IN-DATE
CD3369-40Q: Abbott SJM Quadra Assura MP CRT-D Cardiac Resynchronization Therapy Defibrillator VVED DDDRV
Photos are for illustration purposes only and may not depict the exact item.
Sign in to add this product to your favorites!
| Price: | $4,999.00 $1,249.75 per box of 1 |
|---|---|
| Quantity: | |
| In Stock: | 5 box of 1 |
| Status: | expired |
| Express: | Need it tomorrow? Order in next 14 hours 20 minutes and choose overnight shipping at checkout. |
The item listed above is expired and may be used for educational, training, and non-clinical research purposes only. Any product information appearing below, including the product indication statement, pertains to an in date item only.
Additional Details
Abbott SJM St. Jude Medical Quadra Assura MP Cardiac Resynchronization Therapy Defibrillator
Product Code: CD3369-40D
- Tiered Therapy Cardiverter/Defibrillator
- VVED DDDRV
- Pulse Generator
AccessGUDID Info
- FDA Product Code: NIK
- FDA Product Code Name: Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D)
- GMDN Term Code: 47270
- GMDN Term Name: Cardiac resynchronization therapy implantable defibrillator
- GMDN Term Description: An implantable, battery-powered device consisting of a hermetically-sealed pacing pulse generator and an integrated defibrillation pulse generator with leads in the right ventricle, in a coronary vein over the left ventricle, and often in the right atrium (triple chamber). In addition to conventional pacing and defibrillation functions, the device is intended to provide cardiac resynchronization therapy (CRT) through biventricular electrical stimulation to synchronize right and left ventricular contractions for more effective blood pumping to treat symptoms of heart failure (e.g., shortness of breath, easy fatigue) and serious heart-rhythm problems [CRT defibrillator (CRT-D)].
Manufacturer
Abbott St. Jude Medical has long been a leader in vascular care, through its stents and related products. And, in recent years, the company has built a strong position in mitral valve repair with its MitraClip device. The agreement to acquire St. Jude Medical broadens Abbott's presence in virtually every aspect of cardiovascular care, and will make Abbott one of the world leaders in the broad medical device market.
